2026 NPPES data Medical Oncology Physician NPI 1922034321 M.D.
Verify on CMS →

SOMASEKHAR BANDI, M.D.

Medical Oncology Physician in SAINT LOUIS, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 265 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.7K
32 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SOMASEKHAR BANDI, M.D. is a Medical Oncology Physician ([object Object]) practicing in SAINT LOUIS, Missouri with a Medicare Part D prescribing footprint of 1K claims across 265 beneficiaries — 28% brand-name prescribing . Industry payments of $1.7K across 32 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SOMASEKHAR BANDI, M.D. filed 1,329 Medicare Part D claims in 2023 across SAINT LOUIS, Missouri. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SOMASEKHAR BANDI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SOMASEKHAR BANDI, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 06/25/2006

NPI 1922034321

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

1,329 93% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Missouri

How Medical Oncology Physician compares to other specialties among Missouri providers

Missouri providers

Medical Oncology Physician share within Missouri

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SOMASEKHAR BANDI, M.D. is a Medical Oncology Physician provider practicing in SAINT LOUIS, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1922034321. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SOMASEKHAR BANDI, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 607 S NEW BALLAS RD, SAINT LOUIS, MO, 63141, with a listed phone of (314) 353-1870. NPI 1922034321 was issued on 06/25/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BANDI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,329 prescription claims written by this provider, covering 265 Medicare beneficiaries and totaling roughly $3.3 million in drug spend, split 28% brand-name and 72% generic by claim count, with an opioid prescribing rate of 12.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

607 S NEW BALLAS RD
SAINT LOUIS, MO 63141

Provider Details

NPI 1922034321
Specialty Medical Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/25/2006

Hospital and facility affiliations

Facilities where SOMASEKHAR BANDI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MERCY CLINIC ONCOLOGY LLC
BALLWIN, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SOMASEKHAR BANDI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

SOMASEKHAR BANDI, M.D. — brand share 28.0%
Specialty average (est.)

28% brand-name claims vs 72% generic, on 1,329 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,329
Total Claims
$3.3M
Total Drug Cost
265
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,869
Total Day Supply
50,014
Brand vs Generic
28% brand / 72% generic
Brand Drug Cost
$3.0M
Generic Drug Cost
$332K
Opioid Claims
159 (12.0% rate)
Antibiotic Claims
21

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
2.64
Gender Split
58% female / 42% male
Age Distribution
<65: 27, 65-74: 118, 75-84: 89, 85+: 31

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eliquis
Apixaban
105
Hydroxyurea
91
Ondansetron Hcl
55
Imatinib Mesylate
49
Xarelto
Rivaroxaban
49
Gabapentin
44
Potassium Chloride
40
Dexamethasone
38
Tramadol Hcl
37
Prochlorperazine Maleate
35

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How SOMASEKHAR BANDI, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

SOMASEKHAR BANDI, M.D.'s 1,329 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as BANDI.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SOMASEKHAR BANDI, M.D.'s specialty?
SOMASEKHAR BANDI, M.D. specializes in Medical Oncology Physician and practices in SAINT LOUIS, Missouri. Credentials: M.D..
How much does SOMASEKHAR BANDI, M.D. prescribe under Medicare Part D?
In 2023, SOMASEKHAR BANDI, M.D. wrote 1,329 Medicare Part D claims totaling $3.3M in drug costs for 265 beneficiaries.
Where is SOMASEKHAR BANDI, M.D. located?
SOMASEKHAR BANDI, M.D. is located at 607 S NEW BALLAS RD, SAINT LOUIS, MO, 63141. Phone: (314) 353-1870.
What is SOMASEKHAR BANDI, M.D.'s NPI number?
SOMASEKHAR BANDI, M.D.'s National Provider Identifier (NPI) is 1922034321, issued on 06/25/2006.
Does SOMASEKHAR BANDI, M.D. prescribe more brand-name or generic drugs?
SOMASEKHAR BANDI, M.D.'s prescribing is 28% brand-name and 72% generic drugs by claim count, with $3.0M in brand drug costs.
Does SOMASEKHAR BANDI, M.D. prescribe opioids?
Yes, SOMASEKHAR BANDI, M.D. had 159 opioid claims in 2023 with an opioid prescribing rate of 12.0%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does SOMASEKHAR BANDI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SOMASEKHAR BANDI, M.D.'s most frequently prescribed drugs include Eliquis, Hydroxyurea, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SOMASEKHAR BANDI, M.D. accept Medicare?
SOMASEKHAR BANDI, M.D. appears in CMS Medicare data with 1,329 Part D claims and 265 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SOMASEKHAR BANDI, M.D.'s credentials?
SOMASEKHAR BANDI, M.D.'s NPI is 1922034321 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology